Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Sofia Schuessler"'
Publikováno v:
Cardiology and Therapy, Vol 13, Iss 2, Pp 369-378 (2024)
Abstract Introduction Tafamidis is the first drug approved by the European Commission for the treatment of wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) in adults to reduce cardiovascular mortality and cardiovascular-related
Externí odkaz:
https://doaj.org/article/b41fef91209b4a70bfc1a7d61417730e